Бізнес · 22.11.20131 хв читання
Withdrawal of Approval of New Animal Drug Applications; Carbarsone; Roxarsone
Локальний автоматичний переклад · Оригінальна мова джерела
Короткий зміст
The Food and Drug Administration (FDA) is withdrawing approval of three new animal drug applications (NADAs) for roxarsone or carbarsone Type A medicated articles at the sponsor's request because the products are no longer manufactured or marketed.